| CAS NO: | 1918185-84-8 |
| 包装 | 价格(元) |
| 1mg | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 生物活性 | Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with thePD-L1inhibitor Atezolizumab, may be effective against multiple solid malignancies-most notably non-small cell lungcancer[1][2]. |
| Clinical Trial | |
| 性状 | Liquid |
| CAS 号 | 1918185-84-8 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com